Table 3 Incidence rate and hazard ratio of clinical outcomes in propensity-score-matched population.
N, (%) | ARB group (N = 298) | ACEi group (N = 298) | Hazard Ratio (95% CI) | p-value |
|---|---|---|---|---|
4-year follow up | ||||
MACCE | 26 (9.6) | 35 (12.2) | 0.65 (0.36–1.21) | 0.17 |
Total death | 11 (3.8) | 8 (2.8) | 1.17 (0.39–3.47) | 0.78 |
Cardiac death | 4 (1.4) | 1 (0.3) | 3 (0.31–28.84) | 0.34 |
MI | 5 (1.7) | 3 (1.0) | 2 (0.37–10.92) | 0.42 |
Re-revascularization | 7 (2.4) | 12 (4.2) | 0.78 (0.29–2.10) | 0.62 |
Stroke | 8 (2.8) | 16 (5.6) | 0.50 (0.19–0.33) | 0.17 |
Heart failure | 151 (52.4) | 129 (44.8) | 1.14 (0.87–1.48) | 0.35 |
Graft failure | 7 (2.4) | 6 (2.1) | 1 (0.32–3.10) | 1 |
1-year follow up | ||||
MACCE | 13 (4.5) | 25 (8.7) | 0.46 (0.22–0.96) | 0.04 |
Total death | 4 (1.4) | 2 (0.7) | 4 (0.45–35.79) | 0.22 |
Cardiac death | 3 (1.0) | 0 (0.0) | 7 (0.23–214.37) | 0.19 |
MI | 1 (0.3) | 2 (0.7) | 0.50 (0.05–5.51) | 0.57 |
Re-revascularization | 3 (1.0) | 9 (3.1) | 0.38 (0.10–1.41) | 0.15 |
Stroke | 5 (1.7) | 14 (4.9) | 0.42 (0.14–1.18) | 0.1 |
Heart failure | 3 (1.3) | 0 (0.0) | 7 (0.23–214.37) | 0.27 |
Graft failure | 7 (2.4) | 4 (1.4) | 1.5 (0.42–5.32) | 0.53 |
